I13L (p.Ile13Leu) variant of REL (Proto-oncogene c-Rel)
I13L (p.Ile13Leu) in REL (Proto-oncogene c-Rel) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes variant effect predictions and structural context.
I13L (p.Ile13Leu) variant details
- p.Ile13Leu
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- MetaLR 0.06
- MetaSVM -1.05
- SIFT 0.09
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available